Artemis Investment Management Halves Alliance Pharma Stake To 4.8% (ALLISS)
LONDON (Alliance News) - Alliance Pharma PLC said Wednesday that Artemis Investment Management LLP halved its stake in the company to 4.8%.
Before the transaction the investment management company held a 9.9% stake in the pharmaceutical and consumer healthcare company.
Alliance Pharma shares closed at 84.40 pence, up 3.3%, on Wednesday.
By Elena Cherubini; [email protected]
Copyright 2018 Alliance News Limited. All Rights Reserved.
Register for daily news emails
We have a selection of newsletter options suited to the needs of every investor.To subscribe simply tap the button below: Subscribe now
That page has full facilities for managing your subscriptions. Or, should you choose, unsubscribe.
Any questions — simply contact our customer support team. They will be more than happy to answer your questions.